Cargando…

Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8(+) Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients

SIMPLE SUMMARY: Colorectal cancer is one of the leading causes of global cancer-related mortality. Tumor-infiltrating effector immune cells play critical roles in tumor control, and their activity can dictate disease outcomes. In this study, we provide evidence of the associations between different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsalman, Alhasan, Al-Mterin, Mohammad A., Murshed, Khaled, Alloush, Ferial, Al-Shouli, Samia T., Toor, Salman M., Elkord, Eyad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265020/ https://www.ncbi.nlm.nih.gov/pubmed/35804964 http://dx.doi.org/10.3390/cancers14133194

Ejemplares similares

Correlations between Circulating and Tumor-Infiltrating CD4(+) Treg Subsets with Immune Checkpoints in Colorectal Cancer Patients with Early and Advanced Stages
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Associations of different immune checkpoints-expressing CD4(+) Treg/ T cell subsets with disease-free survival in colorectal cancer patients
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Correlations between Circulating and Tumor-Infiltrating CD4(+) T Cell Subsets with Immune Checkpoints in Colorectal Cancer
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Associations of Complete Blood Count Parameters with Disease-Free Survival in Right- and Left-Sided Colorectal Cancer Patients
por: Alsalman, Alhasan, et al.
Publicado: (2022)

Immune Checkpoints in Circulating and Tumor-Infiltrating CD4(+) T Cell Subsets in Colorectal Cancer Patients
por: Toor, Salman M., et al.
Publicado: (2019)

Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19
por: Alsalman, Alhasan, et al.
Publicado: (2022)

Myeloid Cells in Circulation and Tumor Microenvironment of Colorectal Cancer Patients with Early and Advanced Disease Stages
por: Toor, Salman M., et al.
Publicado: (2020)

Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors
por: Toor, Salman M., et al.
Publicado: (2021)

Differential gene expression of tumor-infiltrating CD33(+) myeloid cells in advanced- versus early-stage colorectal cancer
por: Toor, Salman M., et al.
Publicado: (2020)

Transcriptomic Analyses of Myeloid-Derived Suppressor Cell Subsets in the Circulation of Colorectal Cancer Patients
por: Sasidharan Nair, Varun, et al.
Publicado: (2020)

Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer
por: Sasidharan Nair, Varun, et al.
Publicado: (2020)

Comparison of Myeloid Cells in Circulation and in the Tumor Microenvironment of Patients with Colorectal and Breast Cancers
por: Toor, Salman M., et al.
Publicado: (2017)

Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients
por: Samid, May Abd Al, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
por: Saleh, Reem, et al.
Publicado: (2020)

Differential gene expression of tumor-infiltrating CD4(+) T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis
por: Sasidharan Nair, Varun, et al.
Publicado: (2020)

Differential gene expression of tumor-infiltrating CD8(+) T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis
por: Saleh, Reem, et al.
Publicado: (2020)

Immune checkpoint inhibitors: recent progress and potential biomarkers
por: Darvin, Pramod, et al.
Publicado: (2018)

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
por: Saleh, Reem, et al.
Publicado: (2020)

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4(+) T Cells
por: Saleh, Reem, et al.
Publicado: (2019)

Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4(+) T Cells Associated with Poor Disease-Specific Survival
por: Toor, Salman M., et al.
Publicado: (2021)

Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients
por: Toor, Salman M., et al.
Publicado: (2016)

Helios Should Not Be Cited as a Marker of Human Thymus-Derived Tregs. Commentary: Helios(+) and Helios(−) Cells Coexist within the Natural FOXP3(+) T Regulatory Cell Subset in Humans
por: Elkord, Eyad
Publicado: (2016)

Transcriptomic Profiling of Tumor-Infiltrating CD4(+)TIM-3(+) T Cells Reveals Their Suppressive, Exhausted, and Metastatic Characteristics in Colorectal Cancer Patients
por: Sasidharan Nair, Varun, et al.
Publicado: (2020)

Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP
por: Elkord, Eyad, et al.
Publicado: (2015)

Transcriptomic Analyses Revealed Systemic Alterations in Gene Expression in Circulation and Tumor Microenvironment of Colorectal Cancer Patients
por: Shaath, Hibah, et al.
Publicado: (2019)

Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
por: Toor, Salman M., et al.
Publicado: (2020)

Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants
por: Saleh, Reem, et al.
Publicado: (2020)

RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis
por: Saleh, Reem, et al.
Publicado: (2020)

Myeloid cells in circulation and tumor microenvironment of breast cancer patients
por: Toor, Salman M., et al.
Publicado: (2017)

DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, VISTA and TGF-β genes in HLA-DR(–) myeloid cells, compared with HLA-DR(+) antigen-presenting cells
por: Saleh, Reem, et al.
Publicado: (2020)

Correction to: Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
por: Sasidharan Nair, Varun, et al.
Publicado: (2021)

Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
por: Sasidharan Nair, Varun, et al.
Publicado: (2021)

DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
por: Sasidharan Nair, Varun, et al.
Publicado: (2018)

Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
por: Thomas, Remy, et al.
Publicado: (2020)

T‐cell responses and therapies against SARS‐CoV‐2 infection
por: Toor, Salman M., et al.
Publicado: (2020)

Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer
por: Shaath, Hibah, et al.
Publicado: (2021)

Intratumoral FoxP3(+)Helios(+) Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer
por: Syed Khaja, Azharuddin Sajid, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_skqhet5g171elsb6hp9l4lk1g2